DNA

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were announced today for the matchup…

2 months ago

Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement

ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary…

2 months ago

Soligenix Inc. (NASDAQ: SNGX) Advancing Rare-Disease Therapies Positioned at Pivotal Crossroad

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today announces its placement in…

2 months ago

Powered By Innovation: Murata to Showcase Intelligent System Technologies for Mobility, Wellness, and Connectivity at CES 2026

ATLANTA, Dec. 4, 2025 /PRNewswire/ -- Murata, a global leader in advanced electronics, will join industry leaders at CES 2026 January…

2 months ago

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

AUSTIN, Texas, Dec. 04, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent…

2 months ago

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

One complete response and three partial responses observed in heavily pretreated ICI-secondary refractory patients in high dose cohorts Deep and durable…

2 months ago

Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic Success, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into how mRNA performance can be strengthened through sequence design and GMP-aligned development strategies.…

2 months ago

STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell…

2 months ago

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on…

2 months ago

Embark Showcases Pet Wellness Leadership at Pet Connect USA with Vision for Connected, Personalized Care

*Only Dog Genetics Company Uniting Science, Personalization and Lifelong Guidance Striving to Help Pets Live Longer, Happier, Healthier Lives*LOS ANGELES,…

2 months ago